Silverback Therapeutics Inc (NASDAQ:SBTX)

3.24
Delayed Data
As of May 17
 +0.21 / +6.93%
Today’s Change
2.80
Today|||52-Week Range
35.63
-51.35%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Silverback Therapeutics Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 1.80. The median estimate represents a +8.02% increase from the last price of 3.24.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Silverback Therapeutics Inc. This rating has held steady since April, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.47
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.57%
 
 
 
 
 
 
Growthannually 26.80%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.